Stock·NASDAQ·Technology
AXT Inc. (AXTI)
- Market cap
- $3.80B
- P/E
- 1,539.75
- Dividend yield
- 0.00%
- Street target
- $93.00median of 5 analysts
- 52-week range
- $4.81 $143.16
The short version
Where AXTI stands today, in four lines, and what CleaRank Financial AI makes of it.
AXTI at a glance
AXT Inc. (AXTI): Sell, 21/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($70.81 and $63.05).
- Insiders Insiders sold $78.7M and made no open-market purchases over the last 18 months.
- Valuation P/E of 1,539.8 against 35.1 for the Technology sector: a premium to peers (+4,287%).
Figures as of October 16, 2026.
CleaRank Financial AI
AXT Inc. is trading at $52.06, significantly below its 50-day and 200-day moving averages ($70.81 and $63.05), indicating a bearish technical trend.
The company's valuation is extremely stretched, with a P/E ratio of 1539.75 and a price-to-sales ratio of 32.18, far exceeding sector medians. Despite this, Wall Street analysts maintain a 'Buy' consensus with a median price target of $93.00, suggesting a 78.6% upside. However, the most concerning factor is the heavy insider selling, with over $78.7 million in sales and no reported purchases. The company has demonstrated exceptional revenue growth, with current year estimates at +147.00% and next year projected at +111.00%. The significant insider selling, coupled with the stock's bearish technicals, presents a substantial risk that outweighs the positive analyst outlook and growth projections.
Only on CleaRank
Figures we compute ourselves from AXTI's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $52.06 is 26.5% below the 50-day simple moving average of $70.81.Price above its 200-day average ›
The price is 17.4% below the 200-day simple moving average of $63.05.50-day average above the 200-day ›
The 50-day average ($70.81) is 12.3% above the 200-day average ($63.05), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 34% of its 52-week range, between $4.81 and $143.16.
AXTI share price
Pick a period: each tab shows how far AXTI has moved over it, to the last close.
Today's trading
Where AXTI sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/E below the sector median ›
The trailing P/E of 1,539.75 is 4,286.8% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 32.18 is 323.4% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $3.9M on revenue of $125.5M, a net margin of 3.1%.
Key statistics
The headline figures for AXTI.
As of October 16, 2026, AXTI trades at $52.06, with a market value of $3.80B and a P/E ratio of 1,539.75.
What the numbers say
CleaRank Financial AI's reading of AXTI's valuation, growth and risks.
AXT Inc.'s valuation metrics are exceptionally high, with a P/E ratio of 1539.75 and a price-to-sales ratio of 32.18, which are significantly above the sector medians of 35.1 and 7.6, respectively.
The company's profit margin is 3.23% and its return on equity is 1.01%, which are modest and do not justify the current market capitalization. Despite a low debt-to-equity ratio of 0.11, the company's profitability and valuation appear misaligned. The company's revenue growth is impressive, with current year estimates at +147.00% and next year projected at +111.00%. However, the current EPS is only $0.04, and the price-to-sales ratio suggests that investors are paying a substantial premium for each dollar of revenue. This disconnect between growth expectations and current profitability, coupled with the extreme valuation, presents a significant risk.
AXTI against the Technology sector
How AXTI compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: AXTI trades at a significant premium to sector peers (+4,287%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 6, 2025, AXTI has gained 4,064.8% against a gain of 73.7% for XLK.
Performance against XLK
AXTI and the Technology sector fund over the same days.
Revenue and earnings
How much AXTI sells, and how much of it becomes profit.
Revenue growth: Revenue fell 11.1% in FY2025 to $88.3M, from $99.4M a year earlier.
Profit margin: The net margin was -26.3% in FY2025, down from -11.9% the year before.
Loss-making: AXTI lost $23.2M in FY2025.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 34.0, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 34.0 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of AXTI
The score, the reasoning behind it, and what could move the price next.
AXTI Inc. is trading below its key moving averages, with the 50-day SMA at $70.81 and the 200-day SMA at $63.05, indicating a bearish trend.
The 14-day RSI is at 33.95, classified as bearish, suggesting weakening momentum. Key support levels are not clearly defined given the current downward trend, and resistance is expected at the aforementioned moving averages. The stock's current price action suggests further downside potential until a clear shift in momentum or a significant catalyst emerges to reverse the trend. The lack of volume accompanying the price action indicates a lack of conviction from buyers.
Strong Revenue Growth Projections ›
AXT Inc. is projected to achieve substantial revenue growth, with next year's estimates at +111.00%, which could support future earnings if execution is strong.
Source: Wall Street EstimatesPositive Analyst Consensus and Price Target ›
Despite current headwinds, 5 Wall Street analysts maintain a 'Buy' consensus with a median price target of $93.00, suggesting a 78.6% upside from the current price.
Source: Wall Street Summary
Stock Trading Below Key Moving Averages ›
AXTI is trading below its 50-day SMA ($70.81) and 200-day SMA ($63.05), signaling a bearish technical trend and potential for further price declines.
Source: Technical Analysis
- Given the stock's position below its 50-day and 200-day moving averages ($70.81 and $63.05) and bearish RSI, consider waiting for a clear technical reversal signal before considering any long positions.
Technical indicators
Momentum and trend for AXTI, from its daily closes.
As of October 16, 2026, with AXTI at $52.06, its 14-day RSI is 34.0 (showing bearish momentum without being oversold), its 50-day simple moving average is $70.81 and its 200-day is $63.05.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What AXTI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, AXTI's 1-year correlation of daily returns is +0.31 with S&P 500 (SPY), +0.38 with Nasdaq 100 (QQQ), +0.19 with Bitcoin (BTC) and +0.05 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
4 of 5 analysts rate it a buy or strong buy, 1 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $93.00 is 78.6% above the price.More buy ratings than three months ago ›
4 of 5 rate it a buy now, against 3 of 5 three months ago.
AXTI Wall Street View
12-month price targets
The price, $52.06, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 31, 2026 | B. Riley Securities | Maintains | Neutral |
| Jul 31, 2026 | Needham | Upgrade | Buy |
| Jul 28, 2026 | B. Riley Securities | Maintains | Neutral |
| May 1, 2026 | Wedbush | Maintains | Outperform |
| Apr 29, 2026 | Wedbush | Maintains | Outperform |
As of October 16, 2026, 5 Wall Street analysts cover AXTI: 4 rate it a buy or strong buy, 1 a hold and 0 a sell or strong sell. Their 12-month price targets range from $55.00 to $125.00, with a median of $93.00, 78.6% above the price of $52.06.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AXTI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
AXTI moves about 6.8% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AXTI tends to move, against the market and on its own.
The long record
AXTI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 6.84% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 91.7%, from February 2021 to April 2025, regained by December 2025.Most 1-year holds ended higher ›
45% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $103,596, against $42,525 in the S&P 500 (SPY).
AXTI Drawdowns & Recovery
As of October 16, 2026, AXTI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -91.7% (February 2021 to April 2025); it regained that peak by December 2025, 8 months after the low, and 45% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AXTI in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: AXTI beat the S&P 500 over this period: $103,596 against $42,525.
A $10,000 investment in AXTI in October 2016 would be worth about $103,596 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AXTI, and which have not.
Strongest month, May: an average of +12.49%, up in 7 of 10 years.
Weakest month, June: an average of -3.14%, up in 4 of 10 years.
This month, October: has averaged -1.50%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, AXTI's strongest calendar month has been May (average +12.49%, up in 7 of 10 years) and its weakest June (average -3.14%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AXTI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in AXTI today could grow to about $28,490 by 2036 in the base case, with a 90th-percentile outcome near $216,146 and a 10th-percentile outcome around $3,755. Projections are statistical simulations, not guarantees.
AXTI Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $79.14 for AXTI by 2030 in the base case, from $52.06 today (1.5x over 4 years). The 10th-percentile path ends near $21.97. These are outcomes of a Monte Carlo simulation run on AXTI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $30.46 | $57.81 | $110 | |
| 2028 | $25.93 | $64.19 | $159 | |
| 2029 | $23.49 | $71.27 | $216 | |
| 2030 | $21.97 | $79.14 | $285 | |
| 2031 | $20.97 | $87.87 | $368 |
Method: a lognormal simulation of AXTI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. AXTI is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
AXTI insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought AXTI shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, AXTI insiders reported 33 open-market sales worth $78.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Leonard J Leblanc
Director
|
Sell | 4.0K | $384.3K |
| Aug 7, 2026 | Leonard J Leblanc
Director
|
Sell | 2.5K | $221.4K |
| Jun 15, 2026 | David C Chang
Director
|
Sell | 8.3K | $926.4K |
| Jun 15, 2026 | Jesse Chen
Director
|
Sell | 6.2K | $711.3K |
| Jun 12, 2026 | Jesse Chen
Director
|
Sell | 22.0K | $2.0M |
| Jun 12, 2026 | Morris S Young
Chief Executive Officer
|
Grant | 1.2K | - |
| Jun 10, 2026 | Jesse Chen
Director
|
Sell | 16.5K | $1.5M |
| Jun 4, 2026 | Jesse Chen
Director
|
Sell | 10.1K | $1.1M |
| Jun 4, 2026 | David C Chang
Director
|
Grant | 754 | - |
| Jun 4, 2026 | Jesse Chen
Director
|
Grant | 754 | - |
| Jun 4, 2026 | Leonard J Leblanc
Director
|
Grant | 754 | - |
| Jun 2, 2026 | Morris S Young
Chief Executive Officer
|
Sell | 197.5K | $22.3M |
| Jun 2, 2026 | Jesse Chen
Director
|
Sell | 5.2K | $579.1K |
| Jun 2, 2026 | Morris S Young
Chief Executive Officer
|
Option | 85.7K | $446.5K |
| May 1, 2026 | Morris S Young
Chief Executive Officer
|
Grant | 14.0K | - |
| Mar 13, 2026 | Gary L Fischer
Chief Financial Officer
|
Sell | 89.0K | $4.5M |
| Mar 13, 2026 | Morris S Young
Chief Executive Officer
|
Sell | 37.9K | $1.9M |
| Mar 13, 2026 | Jesse Chen
Director
|
Sell | 14.1K | $700.0K |
| Mar 11, 2026 | Jesse Chen
Director
|
Sell | 29.0K | $1.4M |
| Mar 10, 2026 | Morris S Young
Chief Executive Officer
|
Sell | 30.8K | $1.4M |
| Mar 10, 2026 | David C Chang
Director
|
Sell | 20.0K | $919.9K |
| Mar 9, 2026 | Morris S Young
Chief Executive Officer
|
Sell | 134.2K | $4.9M |
| Mar 9, 2026 | Jesse Chen
Director
|
Sell | 14.5K | $542.6K |
| Mar 5, 2026 | David C Chang
Director
|
Sell | 40.0K | $1.5M |
| Mar 5, 2026 | Jesse Chen
Director
|
Sell | 19.9K | $768.2K |
| Mar 3, 2026 | Jesse Chen
Director
|
Sell | 22.3K | $961.8K |
| Mar 3, 2026 | Morris S Young
Chief Executive Officer
|
Grant | 3.8K | - |
| Mar 2, 2026 | Gary L Fischer
Chief Financial Officer
|
Sell | 405.2K | $16.8M |
| Mar 2, 2026 | Morris S Young
Chief Executive Officer
|
Sell | 159.5K | $6.9M |
| Mar 2, 2026 | Morris S Young
Chief Executive Officer
|
Grant | 27.2K | - |
| Feb 26, 2026 | Gary L Fischer
Chief Financial Officer
|
Option | 247.8K | $1.3M |
| Feb 18, 2026 | Gary L Fischer
Chief Financial Officer
|
Grant | 75.7K | - |
| Feb 18, 2026 | Morris S Young
Chief Executive Officer
|
Grant | 218.2K | - |
| Dec 9, 2025 | David C Chang
Director
|
Sell | 25.0K | $371.0K |
| Dec 9, 2025 | Morris S Young
Chief Executive Officer
|
Grant | 7.8K | - |
| Dec 8, 2025 | Morris S Young
Chief Executive Officer
|
Sell | 37.2K | $462.9K |
| Dec 4, 2025 | Morris S Young
Chief Executive Officer
|
Sell | 35.0K | $421.8K |
| Dec 4, 2025 | Morris S Young
Chief Executive Officer
|
Option | 69.2K | $300.0K |
| Dec 2, 2025 | David C Chang
Director
|
Sell | 50.0K | $576.3K |
| Nov 21, 2025 | Morris S Young
Chief Executive Officer
|
Grant | 15.0K | - |
| Nov 17, 2025 | Morris S Young
Chief Executive Officer
|
Sell | 33.1K | $344.4K |
| Nov 14, 2025 | Morris S Young
Chief Executive Officer
|
Option | 70.0K | $364.7K |
| Nov 13, 2025 | Gary L Fischer
Chief Financial Officer
|
Sell | 101.3K | $1.0M |
| Nov 7, 2025 | Leonard J Leblanc
Director
|
Sell | 3.6K | $30.6K |
| Nov 6, 2025 | Gary L Fischer
Chief Financial Officer
|
Sell | 22.7K | $201.2K |
| Nov 5, 2025 | David C Chang
Director
|
Sell | 100.0K | $894.0K |
| Nov 5, 2025 | Gary L Fischer
Chief Financial Officer
|
Sell | 80.2K | $707.8K |
| Nov 3, 2025 | Morris S Young
Chief Executive Officer
|
Sell | 80.0K | $691.8K |
| Oct 31, 2025 | Morris S Young
Chief Executive Officer
|
Grant | 30.0K | - |
| Oct 28, 2025 | Gary L Fischer
Chief Financial Officer
|
Grant | 37.5K | - |
| Oct 28, 2025 | Morris S Young
Chief Executive Officer
|
Grant | 100.0K | - |
| Oct 20, 2025 | Gary L Fischer
Chief Financial Officer
|
Option | 10.3K | $22.4K |
| Jul 29, 2025 | Leonard J Leblanc
Director
|
Grant | 29.1K | - |
| May 15, 2025 | David C Chang
Director
|
Grant | 55.2K | - |
| May 15, 2025 | Jesse Chen
Director
|
Grant | 55.2K | - |
| May 15, 2025 | Russell Christine
Director
|
Grant | 55.2K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.